The clinical life history of explanted prosthetic heart valves.
This report analyzes 118 prosthetic heart valves obtained from 97 patients at reoperation (96) or at postmortem examination (22). The number obtained from the mitral, aortic, and tricuspid positions were 78, 32, and 8, respectively. Duration of implant ranged from one day to 12.3 years. Valves showing the least long-term wear were the Starr-Edwards metal strut-silicone bell and the Björk-Shiley. Moderate long-term durability was provided by the Beall and Starr-Edwards cloth-covered composite-seat prostheses while short-term durability was given by Hancock and Carpentier valves. Reoperation for valve-related causes was performed for 46 of 47 Beall valves, which demonstrated stenosis, hemolysis, and incompetence from component wear, 6 of 27 Björk-Shiley prostheses for valve thrombosis or thromboembolism or both, and 11 of 17 porcine prostheses because of calcification (4) or cusp perforation or rupture. Analyses of wear and fatigue of mechanical valves demonstrated that use of ultrahard materials (pyrolyte carbon, titanium, stellite 21) provided superior durability in contrast to polymeric solids or fabrics with poor abrasion and impact characteristics. Further, cloth and disc wear were evident as early as 0.5 year after implant and appeared to be complete by 4 years. Completeness of healing after 24 months was not related to the type of fabric material used or its construction. This study suggests that mechanical valves made from hard materials have long durability when properly implanted and require fastidious prophylaxis against infection and thromboembolism. The findings of early cusp perforation or rupture in the aortic position and leaflet calcification, stiffening, or disruption in the mitral position for porcine prostheses suggest that frequent and careful examinations of patients with these prostheses are required to detect early signs of stenosis or incompetence and that early reoperation is required before catastrophic valve failure necessitates emergency prosthetic valve replacement.
D001021:Aortic Valve / Q000601:surgery; D001705:Bioprosthesis / Q000009:adverse effects / Q000401:mortality; D006350:Heart Valve Prosthesis / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D008943:Mitral Valve / Q000601:surgery; D011183:Postoperative Complications; D013997:Time Factors; D014261:Tricuspid Valve / Q000601:surgery